151 related articles for article (PubMed ID: 10805933)
21. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
van der Strate BW; De Boer FM; Bakker HI; Meijer DK; Molema G; Harmsen MC
Antiviral Res; 2003 Apr; 58(2):159-65. PubMed ID: 12742576
[TBL] [Abstract][Full Text] [Related]
22. Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Piret J; Boivin G
Rev Med Virol; 2014 May; 24(3):186-218. PubMed ID: 24604770
[TBL] [Abstract][Full Text] [Related]
23. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
24. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
Cihlar T; Fuller MD; Mulato AS; Cherrington JM
Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
[TBL] [Abstract][Full Text] [Related]
25. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
26. Interpreting human cytomegalovirus antiviral drug susceptibility testing: the role of mixed virus populations.
Baldanti F; Biron KK; Gerna G
J Infect Dis; 1998 Mar; 177(3):823-4. PubMed ID: 9498475
[No Abstract] [Full Text] [Related]
27. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB
Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489
[No Abstract] [Full Text] [Related]
28. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
29. Isolation and analysis of an aciclovir-resistant murine cytomegalovirus mutant.
Minematsu T; Mori S; Eizuru Y; Minamishima Y
Antiviral Res; 2001 Jan; 49(1):25-33. PubMed ID: 11166858
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
Kaneko H; Fujiwara T; Mori S; Shigeta S
Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):786-91. PubMed ID: 11530368
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Kedes DH; Ganem D
J Clin Invest; 1997 May; 99(9):2082-6. PubMed ID: 9151779
[TBL] [Abstract][Full Text] [Related]
33. Selective activity of various antiviral compounds against HHV-7 infection.
Zhang Y; Schols D; De Clercq E
Antiviral Res; 1999 Aug; 43(1):23-35. PubMed ID: 10480261
[TBL] [Abstract][Full Text] [Related]
34. Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats.
Camero M; Crescenzo G; Marinaro M; Tarsitano E; Bellacicco AL; Armenise C; Buonavoglia C; Tempesta M
Antivir Ther; 2010; 15(5):785-8. PubMed ID: 20710060
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of porcine cytomegalovirus to antiviral drugs.
Fryer JF; Griffiths PD; Emery VC; Clark DA
J Antimicrob Chemother; 2004 Jun; 53(6):975-80. PubMed ID: 15117919
[TBL] [Abstract][Full Text] [Related]
37. [Inhibitory effect of foscarnet and acyclovir on reproduction of human herpesvirus 6 in cell culture].
Mel'nichenko AV; L'vov ND; Galegov GA
Antibiot Khimioter; 2009; 54(1-2):17-9. PubMed ID: 19499712
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells.
Akhyani N; Fotheringham J; Yao K; Rashti F; Jacobson S
J Neurovirol; 2006 Aug; 12(4):284-93. PubMed ID: 16966219
[TBL] [Abstract][Full Text] [Related]
39. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir.
Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ
Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]